FDA Inspection 1241011 — Jagsonpal Pharmaceuticals Ltd.
The FDA completed an inspection of Jagsonpal Pharmaceuticals Ltd. on Apr 3, 2024 in Alwar. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 3, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Alwar (India)